What is the initial pathophysiology of exophthalmos in a patient with diffuse goiter, elevated Thyroid-Stimulating Hormone (TSH) and low Triiodothyronine (T3) and Thyroxine (T4) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Exophthalmos in Thyroid Disease

The initial pathophysiology of exophthalmos in the described patient is most likely due to stimulatory anti-TSH receptor antibodies (option B). 1

Understanding the Clinical Presentation

The patient presents with:

  • Diffuse goiter
  • Exophthalmos
  • Elevated TSH
  • Low T3 and T4

This constellation of findings presents an interesting clinical picture. The elevated TSH with low T3 and T4 indicates hypothyroidism, yet the patient has exophthalmos, which is classically associated with Graves' disease (typically hyperthyroidism).

Pathophysiological Mechanism

According to the American Academy of Ophthalmology, thyroid eye disease (TED) can occur in various thyroid states, including hypothyroidism, due to the presence of stimulatory anti-TSH receptor antibodies 1. The pathophysiology involves:

  1. Stimulatory anti-TSH receptor antibodies binding to TSH receptors in orbital fibroblasts
  2. Activation of inflammatory pathways
  3. Production of glycosaminoglycans
  4. Tissue edema development
  5. Resulting proptosis (exophthalmos)

The inferior and medial rectus muscles are most commonly affected in this process 1.

Why Stimulatory Anti-TSH Antibodies?

While the patient has biochemical hypothyroidism (elevated TSH, low T3/T4), the presence of exophthalmos strongly suggests an autoimmune process involving stimulatory anti-TSH receptor antibodies that specifically target orbital tissues. These antibodies can cause orbital inflammation independent of their effect on thyroid function 1.

Research has shown that TED is an autoimmune disorder characterized by:

  • Inflammation and congestion of orbital tissues
  • Enlargement of extraocular muscles
  • Increased orbital fat volume
  • Soft tissue congestion
  • Eyelid retraction
  • Exophthalmos
  • Restrictive extraocular myopathy
  • Potential optic neuropathy 1

Ruling Out Other Options

A. Inhibitory anti-TSH antibodies: While these could explain the hypothyroidism, they would not typically cause the orbital inflammation leading to exophthalmos.

C. T lymphocyte sensitization: While T lymphocytes are involved in the immune response of TED, the initial pathophysiological mechanism involves stimulatory anti-TSH receptor antibodies 2. T lymphocytes play a role in the overall autoimmune process but are not the primary initiating factor for exophthalmos.

D. B lymphocytes: While B lymphocytes produce the antibodies involved in TED, the specific pathophysiology of exophthalmos is directly related to the stimulatory anti-TSH receptor antibodies these cells produce, not the B lymphocytes themselves 1.

Clinical Pearls

  • TED can occur with various thyroid states, including hyperthyroidism, normal-functioning thyroid, and hypothyroidism 1
  • The presence of exophthalmos in a patient with hypothyroidism should raise suspicion for an autoimmune thyroid disorder with associated ophthalmopathy
  • Stimulatory anti-TSH receptor antibodies can cause orbital inflammation even in patients with biochemical hypothyroidism
  • The most frequently affected muscles in TED are the inferior rectus and medial rectus 1

References

Guideline

Thyroid Eye Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.